Medical Data Vision Co Ltd
TSE:3902
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
335
1 689
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
Medical Data Vision Co Ltd
stock under the Base Case scenario is
523.29
JPY.
Compared to the current market price of 1 688 JPY,
Medical Data Vision Co Ltd
is
Overvalued by 69%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Medical Data Vision Co Ltd.
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
|
| JP |
|
M3 Inc
TSE:2413
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
|
| SE |
|
Sectra AB
STO:SECT B
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Medical Data Vision Co Ltd
Balance Sheet Decomposition
Medical Data Vision Co Ltd
| Current Assets | 3.1B |
| Cash & Short-Term Investments | 1.7B |
| Receivables | 864.9m |
| Other Current Assets | 533.2m |
| Non-Current Assets | 1.5B |
| Long-Term Investments | 455m |
| PP&E | 200.5m |
| Intangibles | 45.2m |
| Other Non-Current Assets | 780.2m |
| Current Liabilities | 1.5B |
| Accounts Payable | 224.7m |
| Accrued Liabilities | 31.7m |
| Other Current Liabilities | 1.3B |
| Non-Current Liabilities | 184.4m |
| Other Non-Current Liabilities | 184.4m |
Free Cash Flow Analysis
Medical Data Vision Co Ltd
| JPY | |
| Free Cash Flow | JPY |
Earnings Waterfall
Medical Data Vision Co Ltd
|
Revenue
|
6.4B
JPY
|
|
Cost of Revenue
|
-1.9B
JPY
|
|
Gross Profit
|
4.5B
JPY
|
|
Operating Expenses
|
-4.3B
JPY
|
|
Operating Income
|
240.2m
JPY
|
|
Other Expenses
|
-661.2m
JPY
|
|
Net Income
|
-421m
JPY
|
Profitability Score
Profitability Due Diligence
Medical Data Vision Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
Medical Data Vision Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Medical Data Vision Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
Medical Data Vision Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Medical Data Vision Co Ltd
According to Wall Street analysts, the average 1-year price target for
Medical Data Vision Co Ltd
is 433.5 JPY
with a low forecast of 424.2 JPY and a high forecast of 451.5 JPY.
Dividends
Current shareholder yield for
Medical Data Vision Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Medical Data Vision Co Ltd
stock under the Base Case scenario is
523.29
JPY.
Compared to the current market price of 1 688 JPY,
Medical Data Vision Co Ltd
is
Overvalued by 69%.